DMIIR
Drugs Made In America Acquisition II Corp.
Price Chart
Latest Quote
$0.10
+0.00 (+0.00%)
Current Price
| Previous Close | $0.10 |
| Open | $0.09 |
| Day High | $0.10 |
| Day Low | $0.10 |
| Volume | 104 |
Stock Information
| Total Debt | $450K |
| Cash Equivalents | $348K |
| Net Income | $8.58M |
| Exchange | NGM |
📊 Comprehensive Analysis
Company Data
| Income | $8.58M |
| Book/sh | $-0.28 |
Financial Ratios
| Quick Ratio | 0.52 |
| Current Ratio | 0.53 |
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | -0.36 |
Analyst Data
| Recommendation | none |
Technical Indicators
| Shares Float | 50.26M |
Performance History
| YTD | +0.00% |
⭐ Premium Feature
Sign up for free to view detailed scoring breakdown — premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $0.10 | 104 |
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
📰 Latest News
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.